|4/AMay 19, 4:52 PM ET

VERENIUM CORP 4/A

4/A · VERENIUM CORP · Filed May 19, 2010

Insider Transaction Report

Form 4/AAmended
Period: 2009-11-12
BAUM WILLIAM H
EVP Bioscience Products
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+1,3725,955 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (1,372 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+5026,457 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (502 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+7167,173 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (716 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+2,99413,916 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (2,994 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+3,25517,171 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (3,255 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+592592 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (592 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+3,9914,583 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (3,991 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+3,45910,632 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (3,459 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+29010,922 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (290 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+57817,749 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (578 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+2,13619,885 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (2,136 underlying)
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2009-11-12+91920,804 total
    Exercise: $3.85Exp: 2019-11-12Common Stock (919 underlying)
Footnotes (2)
  • [F1]Granted in exchange for options surrendered pursuant to the Company's stock option exchange program which commenced on 10/13/2009 and terminated 11/12/2009.
  • [F2]Half of the shares are vested on 11/12/2009 and half of the shares vest in a series of eight (8) successive equal quarterly installments measured from the date of grant.

Documents

1 file
  • 4
    edgardoc.xml

    PRIMARY DOCUMENT